Global Human Vaccine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Human Vaccine market size is predicted to grow from US$ 34230 million in 2025 to US$ 45400 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.
East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.
LP Information, Inc. (LPI) ' newest research report, the “Human Vaccine Industry Forecast” looks at past sales and reviews total world Human Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Vaccine sales for 2025 through 2031. With Human Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Human Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Human Vaccine market?
What factors are driving Human Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Vaccine market opportunities vary by end market size?
How does Human Vaccine break out by Type, by Application?
The global Human Vaccine market size is predicted to grow from US$ 34230 million in 2025 to US$ 45400 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.
East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.
LP Information, Inc. (LPI) ' newest research report, the “Human Vaccine Industry Forecast” looks at past sales and reviews total world Human Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Vaccine sales for 2025 through 2031. With Human Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Human Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Varicella
- Influenza
- Polio
- Hepatitis A
- Rabies
- BCG
- Hepatitis B
- Pertussis, Diphtheria, Tetanus
- Pneumococcal
- Rota vaccine
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CNBG
- Changsheng Life
- Zhifei
- ChengDa Bio
- Kangtai
- SINOVAC BIOTECH
- Hissen
- Walvax Biotechnology
- GSK
- SANOFI
- Rong An
- NuoCheng Bio
- Hualan Bio
- Tiantan biological
- Changchun Baike
- Adimmune
- Zhongyianke Biotech
- Bharat Biotech
- Bavarian Nordic
- Sanofi-Pasteur
- Indian Immunologicals
- KANGH
- Henan Grand Biopharma
- ZhongKe Biopharm
- Zhuoyi Biological
What is the 10-year outlook for the global Human Vaccine market?
What factors are driving Human Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Vaccine market opportunities vary by end market size?
How does Human Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Human Vaccine Segment by Type
2.2.1 Varicella
2.2.2 Influenza
2.2.3 Polio
2.2.4 Hepatitis A
2.2.5 Rabies
2.2.6 BCG
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.3 Human Vaccine Sales by Type
2.3.1 Global Human Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Human Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Vaccine Sale Price by Type (2020-2025)
2.4 Human Vaccine Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Human Vaccine Sales by Application
2.5.1 Global Human Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Human Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Vaccine Breakdown Data by Company
3.1.1 Global Human Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Human Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Human Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Human Vaccine Revenue by Company (2020-2025)
3.2.2 Global Human Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Human Vaccine Sale Price by Company
3.4 Key Manufacturers Human Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Vaccine Product Location Distribution
3.4.2 Players Human Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Human Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Human Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Vaccine Sales Growth
4.4 APAC Human Vaccine Sales Growth
4.5 Europe Human Vaccine Sales Growth
4.6 Middle East & Africa Human Vaccine Sales Growth
5 AMERICAS
5.1 Americas Human Vaccine Sales by Country
5.1.1 Americas Human Vaccine Sales by Country (2020-2025)
5.1.2 Americas Human Vaccine Revenue by Country (2020-2025)
5.2 Americas Human Vaccine Sales by Type (2020-2025)
5.3 Americas Human Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Vaccine Sales by Region
6.1.1 APAC Human Vaccine Sales by Region (2020-2025)
6.1.2 APAC Human Vaccine Revenue by Region (2020-2025)
6.2 APAC Human Vaccine Sales by Type (2020-2025)
6.3 APAC Human Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Vaccine by Country
7.1.1 Europe Human Vaccine Sales by Country (2020-2025)
7.1.2 Europe Human Vaccine Revenue by Country (2020-2025)
7.2 Europe Human Vaccine Sales by Type (2020-2025)
7.3 Europe Human Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Vaccine by Country
8.1.1 Middle East & Africa Human Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Human Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Vaccine
10.3 Manufacturing Process Analysis of Human Vaccine
10.4 Industry Chain Structure of Human Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Vaccine Distributors
11.3 Human Vaccine Customer
12 WORLD FORECAST REVIEW FOR HUMAN VACCINE BY GEOGRAPHIC REGION
12.1 Global Human Vaccine Market Size Forecast by Region
12.1.1 Global Human Vaccine Forecast by Region (2026-2031)
12.1.2 Global Human Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Vaccine Forecast by Type (2026-2031)
12.7 Global Human Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CNBG
13.1.1 CNBG Company Information
13.1.2 CNBG Human Vaccine Product Portfolios and Specifications
13.1.3 CNBG Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CNBG Main Business Overview
13.1.5 CNBG Latest Developments
13.2 Changsheng Life
13.2.1 Changsheng Life Company Information
13.2.2 Changsheng Life Human Vaccine Product Portfolios and Specifications
13.2.3 Changsheng Life Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Changsheng Life Main Business Overview
13.2.5 Changsheng Life Latest Developments
13.3 Zhifei
13.3.1 Zhifei Company Information
13.3.2 Zhifei Human Vaccine Product Portfolios and Specifications
13.3.3 Zhifei Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Zhifei Main Business Overview
13.3.5 Zhifei Latest Developments
13.4 ChengDa Bio
13.4.1 ChengDa Bio Company Information
13.4.2 ChengDa Bio Human Vaccine Product Portfolios and Specifications
13.4.3 ChengDa Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 ChengDa Bio Main Business Overview
13.4.5 ChengDa Bio Latest Developments
13.5 Kangtai
13.5.1 Kangtai Company Information
13.5.2 Kangtai Human Vaccine Product Portfolios and Specifications
13.5.3 Kangtai Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kangtai Main Business Overview
13.5.5 Kangtai Latest Developments
13.6 SINOVAC BIOTECH
13.6.1 SINOVAC BIOTECH Company Information
13.6.2 SINOVAC BIOTECH Human Vaccine Product Portfolios and Specifications
13.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SINOVAC BIOTECH Main Business Overview
13.6.5 SINOVAC BIOTECH Latest Developments
13.7 Hissen
13.7.1 Hissen Company Information
13.7.2 Hissen Human Vaccine Product Portfolios and Specifications
13.7.3 Hissen Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hissen Main Business Overview
13.7.5 Hissen Latest Developments
13.8 Walvax Biotechnology
13.8.1 Walvax Biotechnology Company Information
13.8.2 Walvax Biotechnology Human Vaccine Product Portfolios and Specifications
13.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Walvax Biotechnology Main Business Overview
13.8.5 Walvax Biotechnology Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Human Vaccine Product Portfolios and Specifications
13.9.3 GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 SANOFI
13.10.1 SANOFI Company Information
13.10.2 SANOFI Human Vaccine Product Portfolios and Specifications
13.10.3 SANOFI Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 SANOFI Main Business Overview
13.10.5 SANOFI Latest Developments
13.11 Rong An
13.11.1 Rong An Company Information
13.11.2 Rong An Human Vaccine Product Portfolios and Specifications
13.11.3 Rong An Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Rong An Main Business Overview
13.11.5 Rong An Latest Developments
13.12 NuoCheng Bio
13.12.1 NuoCheng Bio Company Information
13.12.2 NuoCheng Bio Human Vaccine Product Portfolios and Specifications
13.12.3 NuoCheng Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 NuoCheng Bio Main Business Overview
13.12.5 NuoCheng Bio Latest Developments
13.13 Hualan Bio
13.13.1 Hualan Bio Company Information
13.13.2 Hualan Bio Human Vaccine Product Portfolios and Specifications
13.13.3 Hualan Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hualan Bio Main Business Overview
13.13.5 Hualan Bio Latest Developments
13.14 Tiantan biological
13.14.1 Tiantan biological Company Information
13.14.2 Tiantan biological Human Vaccine Product Portfolios and Specifications
13.14.3 Tiantan biological Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Tiantan biological Main Business Overview
13.14.5 Tiantan biological Latest Developments
13.15 Changchun Baike
13.15.1 Changchun Baike Company Information
13.15.2 Changchun Baike Human Vaccine Product Portfolios and Specifications
13.15.3 Changchun Baike Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Changchun Baike Main Business Overview
13.15.5 Changchun Baike Latest Developments
13.16 Adimmune
13.16.1 Adimmune Company Information
13.16.2 Adimmune Human Vaccine Product Portfolios and Specifications
13.16.3 Adimmune Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Adimmune Main Business Overview
13.16.5 Adimmune Latest Developments
13.17 Zhongyianke Biotech
13.17.1 Zhongyianke Biotech Company Information
13.17.2 Zhongyianke Biotech Human Vaccine Product Portfolios and Specifications
13.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Zhongyianke Biotech Main Business Overview
13.17.5 Zhongyianke Biotech Latest Developments
13.18 Bharat Biotech
13.18.1 Bharat Biotech Company Information
13.18.2 Bharat Biotech Human Vaccine Product Portfolios and Specifications
13.18.3 Bharat Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Bharat Biotech Main Business Overview
13.18.5 Bharat Biotech Latest Developments
13.19 Bavarian Nordic
13.19.1 Bavarian Nordic Company Information
13.19.2 Bavarian Nordic Human Vaccine Product Portfolios and Specifications
13.19.3 Bavarian Nordic Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Bavarian Nordic Main Business Overview
13.19.5 Bavarian Nordic Latest Developments
13.20 Sanofi-Pasteur
13.20.1 Sanofi-Pasteur Company Information
13.20.2 Sanofi-Pasteur Human Vaccine Product Portfolios and Specifications
13.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Sanofi-Pasteur Main Business Overview
13.20.5 Sanofi-Pasteur Latest Developments
13.21 Indian Immunologicals
13.21.1 Indian Immunologicals Company Information
13.21.2 Indian Immunologicals Human Vaccine Product Portfolios and Specifications
13.21.3 Indian Immunologicals Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Indian Immunologicals Main Business Overview
13.21.5 Indian Immunologicals Latest Developments
13.22 KANGH
13.22.1 KANGH Company Information
13.22.2 KANGH Human Vaccine Product Portfolios and Specifications
13.22.3 KANGH Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 KANGH Main Business Overview
13.22.5 KANGH Latest Developments
13.23 Henan Grand Biopharma
13.23.1 Henan Grand Biopharma Company Information
13.23.2 Henan Grand Biopharma Human Vaccine Product Portfolios and Specifications
13.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Henan Grand Biopharma Main Business Overview
13.23.5 Henan Grand Biopharma Latest Developments
13.24 ZhongKe Biopharm
13.24.1 ZhongKe Biopharm Company Information
13.24.2 ZhongKe Biopharm Human Vaccine Product Portfolios and Specifications
13.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 ZhongKe Biopharm Main Business Overview
13.24.5 ZhongKe Biopharm Latest Developments
13.25 Zhuoyi Biological
13.25.1 Zhuoyi Biological Company Information
13.25.2 Zhuoyi Biological Human Vaccine Product Portfolios and Specifications
13.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 Zhuoyi Biological Main Business Overview
13.25.5 Zhuoyi Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Human Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Varicella
Table 4. Major Players of Influenza
Table 5. Major Players of Polio
Table 6. Major Players of Hepatitis A
Table 7. Major Players of Rabies
Table 8. Major Players of BCG
Table 9. Major Players of Hepatitis B
Table 10. Major Players of Pertussis, Diphtheria,Tetanus
Table 11. Major Players of Pneumococcal
Table 12. Global Human Vaccine Sales byType (2020-2025) & (M Doses)
Table 13. Global Human Vaccine Sales Market Share byType (2020-2025)
Table 14. Global Human Vaccine Revenue byType (2020-2025) & ($ million)
Table 15. Global Human Vaccine Revenue Market Share byType (2020-2025)
Table 16. Global Human Vaccine Sale Price byType (2020-2025) & (USD/Dose)
Table 17. Global Human Vaccine Sale by Application (2020-2025) & (M Doses)
Table 18. Global Human Vaccine Sale Market Share by Application (2020-2025)
Table 19. Global Human Vaccine Revenue by Application (2020-2025) & ($ million)
Table 20. Global Human Vaccine Revenue Market Share by Application (2020-2025)
Table 21. Global Human Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 22. Global Human Vaccine Sales by Company (2020-2025) & (M Doses)
Table 23. Global Human Vaccine Sales Market Share by Company (2020-2025)
Table 24. Global Human Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 25. Global Human Vaccine Revenue Market Share by Company (2020-2025)
Table 26. Global Human Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 27. Key Manufacturers Human Vaccine Producing Area Distribution and Sales Area
Table 28. Players Human Vaccine Products Offered
Table 29. Human Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 30. New Products and Potential Entrants
Table 31. Market M&A Activity & Strategy
Table 32. Global Human Vaccine Sales by Geographic Region (2020-2025) & (M Doses)
Table 33. Global Human Vaccine Sales Market Share Geographic Region (2020-2025)
Table 34. Global Human Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 35. Global Human Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 36. Global Human Vaccine Sales by Country/Region (2020-2025) & (M Doses)
Table 37. Global Human Vaccine Sales Market Share by Country/Region (2020-2025)
Table 38. Global Human Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 39. Global Human Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 40. Americas Human Vaccine Sales by Country (2020-2025) & (M Doses)
Table 41. Americas Human Vaccine Sales Market Share by Country (2020-2025)
Table 42. Americas Human Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 43. Americas Human Vaccine Sales byType (2020-2025) & (M Doses)
Table 44. Americas Human Vaccine Sales by Application (2020-2025) & (M Doses)
Table 45. APAC Human Vaccine Sales by Region (2020-2025) & (M Doses)
Table 46. APAC Human Vaccine Sales Market Share by Region (2020-2025)
Table 47. APAC Human Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 48. APAC Human Vaccine Sales byType (2020-2025) & (M Doses)
Table 49. APAC Human Vaccine Sales by Application (2020-2025) & (M Doses)
Table 50. Europe Human Vaccine Sales by Country (2020-2025) & (M Doses)
Table 51. Europe Human Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 52. Europe Human Vaccine Sales byType (2020-2025) & (M Doses)
Table 53. Europe Human Vaccine Sales by Application (2020-2025) & (M Doses)
Table 54. Middle East & Africa Human Vaccine Sales by Country (2020-2025) & (M Doses)
Table 55. Middle East & Africa Human Vaccine Revenue Market Share by Country (2020-2025)
Table 56. Middle East & Africa Human Vaccine Sales byType (2020-2025) & (M Doses)
Table 57. Middle East & Africa Human Vaccine Sales by Application (2020-2025) & (M Doses)
Table 58. Key Market Drivers & Growth Opportunities of Human Vaccine
Table 59. Key Market Challenges & Risks of Human Vaccine
Table 60. Key IndustryTrends of Human Vaccine
Table 61. Human Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Human Vaccine Distributors List
Table 64. Human Vaccine Customer List
Table 65. Global Human Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 66. Global Human Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Americas Human Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 68. Americas Human Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. APAC Human Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 70. APAC Human Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 71. Europe Human Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 72. Europe Human Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 73. Middle East & Africa Human Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 74. Middle East & Africa Human Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 75. Global Human Vaccine SalesForecast byType (2026-2031) & (M Doses)
Table 76. Global Human Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 77. Global Human Vaccine SalesForecast by Application (2026-2031) & (M Doses)
Table 78. Global Human Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 79. CNBG Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. CNBG Human Vaccine Product Portfolios and Specifications
Table 81. CNBG Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 82. CNBG Main Business
Table 83. CNBG Latest Developments
Table 84. Changsheng Life Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Changsheng Life Human Vaccine Product Portfolios and Specifications
Table 86. Changsheng Life Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 87. Changsheng Life Main Business
Table 88. Changsheng Life Latest Developments
Table 89. Zhifei Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Zhifei Human Vaccine Product Portfolios and Specifications
Table 91. Zhifei Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 92. Zhifei Main Business
Table 93. Zhifei Latest Developments
Table 94. ChengDa Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. ChengDa Bio Human Vaccine Product Portfolios and Specifications
Table 96. ChengDa Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 97. ChengDa Bio Main Business
Table 98. ChengDa Bio Latest Developments
Table 99. Kangtai Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Kangtai Human Vaccine Product Portfolios and Specifications
Table 101. Kangtai Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 102. Kangtai Main Business
Table 103. Kangtai Latest Developments
Table 104. SINOVAC BIOTECH Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. SINOVAC BIOTECH Human Vaccine Product Portfolios and Specifications
Table 106. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 107. SINOVAC BIOTECH Main Business
Table 108. SINOVAC BIOTECH Latest Developments
Table 109. Hissen Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Hissen Human Vaccine Product Portfolios and Specifications
Table 111. Hissen Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 112. Hissen Main Business
Table 113. Hissen Latest Developments
Table 114. Walvax Biotechnology Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Walvax Biotechnology Human Vaccine Product Portfolios and Specifications
Table 116. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 117. Walvax Biotechnology Main Business
Table 118. Walvax Biotechnology Latest Developments
Table 119. GSK Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. GSK Human Vaccine Product Portfolios and Specifications
Table 121. GSK Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 122. GSK Main Business
Table 123. GSK Latest Developments
Table 124. SANOFI Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. SANOFI Human Vaccine Product Portfolios and Specifications
Table 126. SANOFI Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 127. SANOFI Main Business
Table 128. SANOFI Latest Developments
Table 129. Rong An Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Rong An Human Vaccine Product Portfolios and Specifications
Table 131. Rong An Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 132. Rong An Main Business
Table 133. Rong An Latest Developments
Table 134. NuoCheng Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. NuoCheng Bio Human Vaccine Product Portfolios and Specifications
Table 136. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 137. NuoCheng Bio Main Business
Table 138. NuoCheng Bio Latest Developments
Table 139. Hualan Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Hualan Bio Human Vaccine Product Portfolios and Specifications
Table 141. Hualan Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 142. Hualan Bio Main Business
Table 143. Hualan Bio Latest Developments
Table 144.Tiantan biological Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 145.Tiantan biological Human Vaccine Product Portfolios and Specifications
Table 146.Tiantan biological Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 147.Tiantan biological Main Business
Table 148.Tiantan biological Latest Developments
Table 149. Changchun Baike Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 150. Changchun Baike Human Vaccine Product Portfolios and Specifications
Table 151. Changchun Baike Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 152. Changchun Baike Main Business
Table 153. Changchun Baike Latest Developments
Table 154. Adimmune Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 155. Adimmune Human Vaccine Product Portfolios and Specifications
Table 156. Adimmune Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 157. Adimmune Main Business
Table 158. Adimmune Latest Developments
Table 159. Zhongyianke Biotech Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 160. Zhongyianke Biotech Human Vaccine Product Portfolios and Specifications
Table 161. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 162. Zhongyianke Biotech Main Business
Table 163. Zhongyianke Biotech Latest Developments
Table 164. Bharat Biotech Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 165. Bharat Biotech Human Vaccine Product Portfolios and Specifications
Table 166. Bharat Biotech Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 167. Bharat Biotech Main Business
Table 168. Bharat Biotech Latest Developments
Table 169. Bavarian Nordic Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 170. Bavarian Nordic Human Vaccine Product Portfolios and Specifications
Table 171. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 172. Bavarian Nordic Main Business
Table 173. Bavarian Nordic Latest Developments
Table 174. Sanofi-Pasteur Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 175. Sanofi-Pasteur Human Vaccine Product Portfolios and Specifications
Table 176. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 177. Sanofi-Pasteur Main Business
Table 178. Sanofi-Pasteur Latest Developments
Table 179. Indian Immunologicals Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 180. Indian Immunologicals Human Vaccine Product Portfolios and Specifications
Table 181. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 182. Indian Immunologicals Main Business
Table 183. Indian Immunologicals Latest Developments
Table 184. KANGH Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 185. KANGH Human Vaccine Product Portfolios and Specifications
Table 186. KANGH Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 187. KANGH Main Business
Table 188. KANGH Latest Developments
Table 189. Henan Grand Biopharma Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 190. Henan Grand Biopharma Human Vaccine Product Portfolios and Specifications
Table 191. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 192. Henan Grand Biopharma Main Business
Table 193. Henan Grand Biopharma Latest Developments
Table 194. ZhongKe Biopharm Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 195. ZhongKe Biopharm Human Vaccine Product Portfolios and Specifications
Table 196. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 197. ZhongKe Biopharm Main Business
Table 198. ZhongKe Biopharm Latest Developments
Table 199. Zhuoyi Biological Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 200. Zhuoyi Biological Human Vaccine Product Portfolios and Specifications
Table 201. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 202. Zhuoyi Biological Main Business
Table 203. Zhuoyi Biological Latest Developments
LIST OFFIGURES
Figure 1. Picture of Human Vaccine
Figure 2. Human Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Vaccine Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Human Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Human Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Varicella
Figure 12. Product Picture of Influenza
Figure 13. Product Picture of Polio
Figure 14. Product Picture of Hepatitis A
Figure 15. Product Picture of Rabies
Figure 16. Product Picture of BCG
Figure 17. Product Picture of Hepatitis B
Figure 18. Product Picture of Pertussis, Diphtheria,Tetanus
Figure 19. Product Picture of Pneumococcal
Figure 20. Global Human Vaccine Sales Market Share byType in 2025
Figure 21. Global Human Vaccine Revenue Market Share byType (2020-2025)
Figure 22. Human Vaccine Consumed in Adults
Figure 23. Global Human Vaccine Market: Adults (2020-2025) & (M Doses)
Figure 24. Human Vaccine Consumed in Children
Figure 25. Global Human Vaccine Market: Children (2020-2025) & (M Doses)
Figure 26. Global Human Vaccine Sale Market Share by Application (2024)
Figure 27. Global Human Vaccine Revenue Market Share by Application in 2025
Figure 28. Human Vaccine Sales by Company in 2025 (M Doses)
Figure 29. Global Human Vaccine Sales Market Share by Company in 2025
Figure 30. Human Vaccine Revenue by Company in 2025 ($ millions)
Figure 31. Global Human Vaccine Revenue Market Share by Company in 2025
Figure 32. Global Human Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Human Vaccine Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Human Vaccine Sales 2020-2025 (M Doses)
Figure 35. Americas Human Vaccine Revenue 2020-2025 ($ millions)
Figure 36. APAC Human Vaccine Sales 2020-2025 (M Doses)
Figure 37. APAC Human Vaccine Revenue 2020-2025 ($ millions)
Figure 38. Europe Human Vaccine Sales 2020-2025 (M Doses)
Figure 39. Europe Human Vaccine Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Human Vaccine Sales 2020-2025 (M Doses)
Figure 41. Middle East & Africa Human Vaccine Revenue 2020-2025 ($ millions)
Figure 42. Americas Human Vaccine Sales Market Share by Country in 2025
Figure 43. Americas Human Vaccine Revenue Market Share by Country (2020-2025)
Figure 44. Americas Human Vaccine Sales Market Share byType (2020-2025)
Figure 45. Americas Human Vaccine Sales Market Share by Application (2020-2025)
Figure 46. United States Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Human Vaccine Sales Market Share by Region in 2025
Figure 51. APAC Human Vaccine Revenue Market Share by Region (2020-2025)
Figure 52. APAC Human Vaccine Sales Market Share byType (2020-2025)
Figure 53. APAC Human Vaccine Sales Market Share by Application (2020-2025)
Figure 54. China Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. India Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Human Vaccine Sales Market Share by Country in 2025
Figure 62. Europe Human Vaccine Revenue Market Share by Country (2020-2025)
Figure 63. Europe Human Vaccine Sales Market Share byType (2020-2025)
Figure 64. Europe Human Vaccine Sales Market Share by Application (2020-2025)
Figure 65. Germany Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66.France Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Human Vaccine Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Human Vaccine Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Human Vaccine Sales Market Share by Application (2020-2025)
Figure 73. Egypt Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Human Vaccine in 2025
Figure 79. Manufacturing Process Analysis of Human Vaccine
Figure 80. Industry Chain Structure of Human Vaccine
Figure 81. Channels of Distribution
Figure 82. Global Human Vaccine Sales MarketForecast by Region (2026-2031)
Figure 83. Global Human Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Human Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Human Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Human Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Human Vaccine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Human Vaccine Segment by Type
2.2.1 Varicella
2.2.2 Influenza
2.2.3 Polio
2.2.4 Hepatitis A
2.2.5 Rabies
2.2.6 BCG
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.3 Human Vaccine Sales by Type
2.3.1 Global Human Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Human Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Vaccine Sale Price by Type (2020-2025)
2.4 Human Vaccine Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Human Vaccine Sales by Application
2.5.1 Global Human Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Human Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Vaccine Breakdown Data by Company
3.1.1 Global Human Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Human Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Human Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Human Vaccine Revenue by Company (2020-2025)
3.2.2 Global Human Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Human Vaccine Sale Price by Company
3.4 Key Manufacturers Human Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Vaccine Product Location Distribution
3.4.2 Players Human Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Human Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Human Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Vaccine Sales Growth
4.4 APAC Human Vaccine Sales Growth
4.5 Europe Human Vaccine Sales Growth
4.6 Middle East & Africa Human Vaccine Sales Growth
5 AMERICAS
5.1 Americas Human Vaccine Sales by Country
5.1.1 Americas Human Vaccine Sales by Country (2020-2025)
5.1.2 Americas Human Vaccine Revenue by Country (2020-2025)
5.2 Americas Human Vaccine Sales by Type (2020-2025)
5.3 Americas Human Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Vaccine Sales by Region
6.1.1 APAC Human Vaccine Sales by Region (2020-2025)
6.1.2 APAC Human Vaccine Revenue by Region (2020-2025)
6.2 APAC Human Vaccine Sales by Type (2020-2025)
6.3 APAC Human Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Vaccine by Country
7.1.1 Europe Human Vaccine Sales by Country (2020-2025)
7.1.2 Europe Human Vaccine Revenue by Country (2020-2025)
7.2 Europe Human Vaccine Sales by Type (2020-2025)
7.3 Europe Human Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Vaccine by Country
8.1.1 Middle East & Africa Human Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Human Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Vaccine
10.3 Manufacturing Process Analysis of Human Vaccine
10.4 Industry Chain Structure of Human Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Vaccine Distributors
11.3 Human Vaccine Customer
12 WORLD FORECAST REVIEW FOR HUMAN VACCINE BY GEOGRAPHIC REGION
12.1 Global Human Vaccine Market Size Forecast by Region
12.1.1 Global Human Vaccine Forecast by Region (2026-2031)
12.1.2 Global Human Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Vaccine Forecast by Type (2026-2031)
12.7 Global Human Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CNBG
13.1.1 CNBG Company Information
13.1.2 CNBG Human Vaccine Product Portfolios and Specifications
13.1.3 CNBG Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CNBG Main Business Overview
13.1.5 CNBG Latest Developments
13.2 Changsheng Life
13.2.1 Changsheng Life Company Information
13.2.2 Changsheng Life Human Vaccine Product Portfolios and Specifications
13.2.3 Changsheng Life Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Changsheng Life Main Business Overview
13.2.5 Changsheng Life Latest Developments
13.3 Zhifei
13.3.1 Zhifei Company Information
13.3.2 Zhifei Human Vaccine Product Portfolios and Specifications
13.3.3 Zhifei Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Zhifei Main Business Overview
13.3.5 Zhifei Latest Developments
13.4 ChengDa Bio
13.4.1 ChengDa Bio Company Information
13.4.2 ChengDa Bio Human Vaccine Product Portfolios and Specifications
13.4.3 ChengDa Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 ChengDa Bio Main Business Overview
13.4.5 ChengDa Bio Latest Developments
13.5 Kangtai
13.5.1 Kangtai Company Information
13.5.2 Kangtai Human Vaccine Product Portfolios and Specifications
13.5.3 Kangtai Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kangtai Main Business Overview
13.5.5 Kangtai Latest Developments
13.6 SINOVAC BIOTECH
13.6.1 SINOVAC BIOTECH Company Information
13.6.2 SINOVAC BIOTECH Human Vaccine Product Portfolios and Specifications
13.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SINOVAC BIOTECH Main Business Overview
13.6.5 SINOVAC BIOTECH Latest Developments
13.7 Hissen
13.7.1 Hissen Company Information
13.7.2 Hissen Human Vaccine Product Portfolios and Specifications
13.7.3 Hissen Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hissen Main Business Overview
13.7.5 Hissen Latest Developments
13.8 Walvax Biotechnology
13.8.1 Walvax Biotechnology Company Information
13.8.2 Walvax Biotechnology Human Vaccine Product Portfolios and Specifications
13.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Walvax Biotechnology Main Business Overview
13.8.5 Walvax Biotechnology Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Human Vaccine Product Portfolios and Specifications
13.9.3 GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 SANOFI
13.10.1 SANOFI Company Information
13.10.2 SANOFI Human Vaccine Product Portfolios and Specifications
13.10.3 SANOFI Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 SANOFI Main Business Overview
13.10.5 SANOFI Latest Developments
13.11 Rong An
13.11.1 Rong An Company Information
13.11.2 Rong An Human Vaccine Product Portfolios and Specifications
13.11.3 Rong An Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Rong An Main Business Overview
13.11.5 Rong An Latest Developments
13.12 NuoCheng Bio
13.12.1 NuoCheng Bio Company Information
13.12.2 NuoCheng Bio Human Vaccine Product Portfolios and Specifications
13.12.3 NuoCheng Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 NuoCheng Bio Main Business Overview
13.12.5 NuoCheng Bio Latest Developments
13.13 Hualan Bio
13.13.1 Hualan Bio Company Information
13.13.2 Hualan Bio Human Vaccine Product Portfolios and Specifications
13.13.3 Hualan Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hualan Bio Main Business Overview
13.13.5 Hualan Bio Latest Developments
13.14 Tiantan biological
13.14.1 Tiantan biological Company Information
13.14.2 Tiantan biological Human Vaccine Product Portfolios and Specifications
13.14.3 Tiantan biological Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Tiantan biological Main Business Overview
13.14.5 Tiantan biological Latest Developments
13.15 Changchun Baike
13.15.1 Changchun Baike Company Information
13.15.2 Changchun Baike Human Vaccine Product Portfolios and Specifications
13.15.3 Changchun Baike Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Changchun Baike Main Business Overview
13.15.5 Changchun Baike Latest Developments
13.16 Adimmune
13.16.1 Adimmune Company Information
13.16.2 Adimmune Human Vaccine Product Portfolios and Specifications
13.16.3 Adimmune Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Adimmune Main Business Overview
13.16.5 Adimmune Latest Developments
13.17 Zhongyianke Biotech
13.17.1 Zhongyianke Biotech Company Information
13.17.2 Zhongyianke Biotech Human Vaccine Product Portfolios and Specifications
13.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Zhongyianke Biotech Main Business Overview
13.17.5 Zhongyianke Biotech Latest Developments
13.18 Bharat Biotech
13.18.1 Bharat Biotech Company Information
13.18.2 Bharat Biotech Human Vaccine Product Portfolios and Specifications
13.18.3 Bharat Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Bharat Biotech Main Business Overview
13.18.5 Bharat Biotech Latest Developments
13.19 Bavarian Nordic
13.19.1 Bavarian Nordic Company Information
13.19.2 Bavarian Nordic Human Vaccine Product Portfolios and Specifications
13.19.3 Bavarian Nordic Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Bavarian Nordic Main Business Overview
13.19.5 Bavarian Nordic Latest Developments
13.20 Sanofi-Pasteur
13.20.1 Sanofi-Pasteur Company Information
13.20.2 Sanofi-Pasteur Human Vaccine Product Portfolios and Specifications
13.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Sanofi-Pasteur Main Business Overview
13.20.5 Sanofi-Pasteur Latest Developments
13.21 Indian Immunologicals
13.21.1 Indian Immunologicals Company Information
13.21.2 Indian Immunologicals Human Vaccine Product Portfolios and Specifications
13.21.3 Indian Immunologicals Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Indian Immunologicals Main Business Overview
13.21.5 Indian Immunologicals Latest Developments
13.22 KANGH
13.22.1 KANGH Company Information
13.22.2 KANGH Human Vaccine Product Portfolios and Specifications
13.22.3 KANGH Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 KANGH Main Business Overview
13.22.5 KANGH Latest Developments
13.23 Henan Grand Biopharma
13.23.1 Henan Grand Biopharma Company Information
13.23.2 Henan Grand Biopharma Human Vaccine Product Portfolios and Specifications
13.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Henan Grand Biopharma Main Business Overview
13.23.5 Henan Grand Biopharma Latest Developments
13.24 ZhongKe Biopharm
13.24.1 ZhongKe Biopharm Company Information
13.24.2 ZhongKe Biopharm Human Vaccine Product Portfolios and Specifications
13.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 ZhongKe Biopharm Main Business Overview
13.24.5 ZhongKe Biopharm Latest Developments
13.25 Zhuoyi Biological
13.25.1 Zhuoyi Biological Company Information
13.25.2 Zhuoyi Biological Human Vaccine Product Portfolios and Specifications
13.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 Zhuoyi Biological Main Business Overview
13.25.5 Zhuoyi Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Human Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Varicella
Table 4. Major Players of Influenza
Table 5. Major Players of Polio
Table 6. Major Players of Hepatitis A
Table 7. Major Players of Rabies
Table 8. Major Players of BCG
Table 9. Major Players of Hepatitis B
Table 10. Major Players of Pertussis, Diphtheria,Tetanus
Table 11. Major Players of Pneumococcal
Table 12. Global Human Vaccine Sales byType (2020-2025) & (M Doses)
Table 13. Global Human Vaccine Sales Market Share byType (2020-2025)
Table 14. Global Human Vaccine Revenue byType (2020-2025) & ($ million)
Table 15. Global Human Vaccine Revenue Market Share byType (2020-2025)
Table 16. Global Human Vaccine Sale Price byType (2020-2025) & (USD/Dose)
Table 17. Global Human Vaccine Sale by Application (2020-2025) & (M Doses)
Table 18. Global Human Vaccine Sale Market Share by Application (2020-2025)
Table 19. Global Human Vaccine Revenue by Application (2020-2025) & ($ million)
Table 20. Global Human Vaccine Revenue Market Share by Application (2020-2025)
Table 21. Global Human Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 22. Global Human Vaccine Sales by Company (2020-2025) & (M Doses)
Table 23. Global Human Vaccine Sales Market Share by Company (2020-2025)
Table 24. Global Human Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 25. Global Human Vaccine Revenue Market Share by Company (2020-2025)
Table 26. Global Human Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 27. Key Manufacturers Human Vaccine Producing Area Distribution and Sales Area
Table 28. Players Human Vaccine Products Offered
Table 29. Human Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 30. New Products and Potential Entrants
Table 31. Market M&A Activity & Strategy
Table 32. Global Human Vaccine Sales by Geographic Region (2020-2025) & (M Doses)
Table 33. Global Human Vaccine Sales Market Share Geographic Region (2020-2025)
Table 34. Global Human Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 35. Global Human Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 36. Global Human Vaccine Sales by Country/Region (2020-2025) & (M Doses)
Table 37. Global Human Vaccine Sales Market Share by Country/Region (2020-2025)
Table 38. Global Human Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 39. Global Human Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 40. Americas Human Vaccine Sales by Country (2020-2025) & (M Doses)
Table 41. Americas Human Vaccine Sales Market Share by Country (2020-2025)
Table 42. Americas Human Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 43. Americas Human Vaccine Sales byType (2020-2025) & (M Doses)
Table 44. Americas Human Vaccine Sales by Application (2020-2025) & (M Doses)
Table 45. APAC Human Vaccine Sales by Region (2020-2025) & (M Doses)
Table 46. APAC Human Vaccine Sales Market Share by Region (2020-2025)
Table 47. APAC Human Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 48. APAC Human Vaccine Sales byType (2020-2025) & (M Doses)
Table 49. APAC Human Vaccine Sales by Application (2020-2025) & (M Doses)
Table 50. Europe Human Vaccine Sales by Country (2020-2025) & (M Doses)
Table 51. Europe Human Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 52. Europe Human Vaccine Sales byType (2020-2025) & (M Doses)
Table 53. Europe Human Vaccine Sales by Application (2020-2025) & (M Doses)
Table 54. Middle East & Africa Human Vaccine Sales by Country (2020-2025) & (M Doses)
Table 55. Middle East & Africa Human Vaccine Revenue Market Share by Country (2020-2025)
Table 56. Middle East & Africa Human Vaccine Sales byType (2020-2025) & (M Doses)
Table 57. Middle East & Africa Human Vaccine Sales by Application (2020-2025) & (M Doses)
Table 58. Key Market Drivers & Growth Opportunities of Human Vaccine
Table 59. Key Market Challenges & Risks of Human Vaccine
Table 60. Key IndustryTrends of Human Vaccine
Table 61. Human Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Human Vaccine Distributors List
Table 64. Human Vaccine Customer List
Table 65. Global Human Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 66. Global Human Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Americas Human Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 68. Americas Human Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. APAC Human Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 70. APAC Human Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 71. Europe Human Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 72. Europe Human Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 73. Middle East & Africa Human Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 74. Middle East & Africa Human Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 75. Global Human Vaccine SalesForecast byType (2026-2031) & (M Doses)
Table 76. Global Human Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 77. Global Human Vaccine SalesForecast by Application (2026-2031) & (M Doses)
Table 78. Global Human Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 79. CNBG Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. CNBG Human Vaccine Product Portfolios and Specifications
Table 81. CNBG Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 82. CNBG Main Business
Table 83. CNBG Latest Developments
Table 84. Changsheng Life Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Changsheng Life Human Vaccine Product Portfolios and Specifications
Table 86. Changsheng Life Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 87. Changsheng Life Main Business
Table 88. Changsheng Life Latest Developments
Table 89. Zhifei Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Zhifei Human Vaccine Product Portfolios and Specifications
Table 91. Zhifei Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 92. Zhifei Main Business
Table 93. Zhifei Latest Developments
Table 94. ChengDa Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. ChengDa Bio Human Vaccine Product Portfolios and Specifications
Table 96. ChengDa Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 97. ChengDa Bio Main Business
Table 98. ChengDa Bio Latest Developments
Table 99. Kangtai Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Kangtai Human Vaccine Product Portfolios and Specifications
Table 101. Kangtai Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 102. Kangtai Main Business
Table 103. Kangtai Latest Developments
Table 104. SINOVAC BIOTECH Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. SINOVAC BIOTECH Human Vaccine Product Portfolios and Specifications
Table 106. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 107. SINOVAC BIOTECH Main Business
Table 108. SINOVAC BIOTECH Latest Developments
Table 109. Hissen Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Hissen Human Vaccine Product Portfolios and Specifications
Table 111. Hissen Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 112. Hissen Main Business
Table 113. Hissen Latest Developments
Table 114. Walvax Biotechnology Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Walvax Biotechnology Human Vaccine Product Portfolios and Specifications
Table 116. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 117. Walvax Biotechnology Main Business
Table 118. Walvax Biotechnology Latest Developments
Table 119. GSK Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. GSK Human Vaccine Product Portfolios and Specifications
Table 121. GSK Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 122. GSK Main Business
Table 123. GSK Latest Developments
Table 124. SANOFI Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. SANOFI Human Vaccine Product Portfolios and Specifications
Table 126. SANOFI Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 127. SANOFI Main Business
Table 128. SANOFI Latest Developments
Table 129. Rong An Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Rong An Human Vaccine Product Portfolios and Specifications
Table 131. Rong An Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 132. Rong An Main Business
Table 133. Rong An Latest Developments
Table 134. NuoCheng Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. NuoCheng Bio Human Vaccine Product Portfolios and Specifications
Table 136. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 137. NuoCheng Bio Main Business
Table 138. NuoCheng Bio Latest Developments
Table 139. Hualan Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Hualan Bio Human Vaccine Product Portfolios and Specifications
Table 141. Hualan Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 142. Hualan Bio Main Business
Table 143. Hualan Bio Latest Developments
Table 144.Tiantan biological Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 145.Tiantan biological Human Vaccine Product Portfolios and Specifications
Table 146.Tiantan biological Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 147.Tiantan biological Main Business
Table 148.Tiantan biological Latest Developments
Table 149. Changchun Baike Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 150. Changchun Baike Human Vaccine Product Portfolios and Specifications
Table 151. Changchun Baike Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 152. Changchun Baike Main Business
Table 153. Changchun Baike Latest Developments
Table 154. Adimmune Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 155. Adimmune Human Vaccine Product Portfolios and Specifications
Table 156. Adimmune Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 157. Adimmune Main Business
Table 158. Adimmune Latest Developments
Table 159. Zhongyianke Biotech Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 160. Zhongyianke Biotech Human Vaccine Product Portfolios and Specifications
Table 161. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 162. Zhongyianke Biotech Main Business
Table 163. Zhongyianke Biotech Latest Developments
Table 164. Bharat Biotech Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 165. Bharat Biotech Human Vaccine Product Portfolios and Specifications
Table 166. Bharat Biotech Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 167. Bharat Biotech Main Business
Table 168. Bharat Biotech Latest Developments
Table 169. Bavarian Nordic Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 170. Bavarian Nordic Human Vaccine Product Portfolios and Specifications
Table 171. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 172. Bavarian Nordic Main Business
Table 173. Bavarian Nordic Latest Developments
Table 174. Sanofi-Pasteur Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 175. Sanofi-Pasteur Human Vaccine Product Portfolios and Specifications
Table 176. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 177. Sanofi-Pasteur Main Business
Table 178. Sanofi-Pasteur Latest Developments
Table 179. Indian Immunologicals Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 180. Indian Immunologicals Human Vaccine Product Portfolios and Specifications
Table 181. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 182. Indian Immunologicals Main Business
Table 183. Indian Immunologicals Latest Developments
Table 184. KANGH Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 185. KANGH Human Vaccine Product Portfolios and Specifications
Table 186. KANGH Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 187. KANGH Main Business
Table 188. KANGH Latest Developments
Table 189. Henan Grand Biopharma Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 190. Henan Grand Biopharma Human Vaccine Product Portfolios and Specifications
Table 191. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 192. Henan Grand Biopharma Main Business
Table 193. Henan Grand Biopharma Latest Developments
Table 194. ZhongKe Biopharm Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 195. ZhongKe Biopharm Human Vaccine Product Portfolios and Specifications
Table 196. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 197. ZhongKe Biopharm Main Business
Table 198. ZhongKe Biopharm Latest Developments
Table 199. Zhuoyi Biological Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 200. Zhuoyi Biological Human Vaccine Product Portfolios and Specifications
Table 201. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 202. Zhuoyi Biological Main Business
Table 203. Zhuoyi Biological Latest Developments
LIST OFFIGURES
Figure 1. Picture of Human Vaccine
Figure 2. Human Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Vaccine Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Human Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Human Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Varicella
Figure 12. Product Picture of Influenza
Figure 13. Product Picture of Polio
Figure 14. Product Picture of Hepatitis A
Figure 15. Product Picture of Rabies
Figure 16. Product Picture of BCG
Figure 17. Product Picture of Hepatitis B
Figure 18. Product Picture of Pertussis, Diphtheria,Tetanus
Figure 19. Product Picture of Pneumococcal
Figure 20. Global Human Vaccine Sales Market Share byType in 2025
Figure 21. Global Human Vaccine Revenue Market Share byType (2020-2025)
Figure 22. Human Vaccine Consumed in Adults
Figure 23. Global Human Vaccine Market: Adults (2020-2025) & (M Doses)
Figure 24. Human Vaccine Consumed in Children
Figure 25. Global Human Vaccine Market: Children (2020-2025) & (M Doses)
Figure 26. Global Human Vaccine Sale Market Share by Application (2024)
Figure 27. Global Human Vaccine Revenue Market Share by Application in 2025
Figure 28. Human Vaccine Sales by Company in 2025 (M Doses)
Figure 29. Global Human Vaccine Sales Market Share by Company in 2025
Figure 30. Human Vaccine Revenue by Company in 2025 ($ millions)
Figure 31. Global Human Vaccine Revenue Market Share by Company in 2025
Figure 32. Global Human Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Human Vaccine Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Human Vaccine Sales 2020-2025 (M Doses)
Figure 35. Americas Human Vaccine Revenue 2020-2025 ($ millions)
Figure 36. APAC Human Vaccine Sales 2020-2025 (M Doses)
Figure 37. APAC Human Vaccine Revenue 2020-2025 ($ millions)
Figure 38. Europe Human Vaccine Sales 2020-2025 (M Doses)
Figure 39. Europe Human Vaccine Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Human Vaccine Sales 2020-2025 (M Doses)
Figure 41. Middle East & Africa Human Vaccine Revenue 2020-2025 ($ millions)
Figure 42. Americas Human Vaccine Sales Market Share by Country in 2025
Figure 43. Americas Human Vaccine Revenue Market Share by Country (2020-2025)
Figure 44. Americas Human Vaccine Sales Market Share byType (2020-2025)
Figure 45. Americas Human Vaccine Sales Market Share by Application (2020-2025)
Figure 46. United States Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Human Vaccine Sales Market Share by Region in 2025
Figure 51. APAC Human Vaccine Revenue Market Share by Region (2020-2025)
Figure 52. APAC Human Vaccine Sales Market Share byType (2020-2025)
Figure 53. APAC Human Vaccine Sales Market Share by Application (2020-2025)
Figure 54. China Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. India Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Human Vaccine Sales Market Share by Country in 2025
Figure 62. Europe Human Vaccine Revenue Market Share by Country (2020-2025)
Figure 63. Europe Human Vaccine Sales Market Share byType (2020-2025)
Figure 64. Europe Human Vaccine Sales Market Share by Application (2020-2025)
Figure 65. Germany Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66.France Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Human Vaccine Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Human Vaccine Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Human Vaccine Sales Market Share by Application (2020-2025)
Figure 73. Egypt Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Human Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Human Vaccine in 2025
Figure 79. Manufacturing Process Analysis of Human Vaccine
Figure 80. Industry Chain Structure of Human Vaccine
Figure 81. Channels of Distribution
Figure 82. Global Human Vaccine Sales MarketForecast by Region (2026-2031)
Figure 83. Global Human Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Human Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Human Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Human Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Human Vaccine Revenue Market ShareForecast by Application (2026-2031)
